Form 4 for RANI Rani Therapeutics Holdings, Inc.
Accepted 2022-02-07 00:00:00 ET · period of report 2022-02-03 · accession 0001209191-22-007647 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2022-02-07 | 2022-02-03 | RANI | Imran Talat | CEO, Dir | J - Other | $0.00 | -815.1K | 12.3K | -99% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-02-03 | J | D | 827,467 | $0.00 | 0 | I See footnote | — | — | (F2) Represents previously held 378,564 shares of Class A Common Stock of the Issuer ("Class A Shares") held by Biologix Partners, LP and 448,903 Class A Shares held by VH Rani, LP. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. |
| 2 | Common | Class A Common Stock | 2022-02-03 | J | A | 12,343 | $0.00 | 12,343 | I See footnote | — | — | (F3) VH Moll, L.P., is a limited partner of VH Rani, LP. VH Moll, L.P. therefore received 12,343 Class A Shares distributed by VH Rani, LP. and now owns those shares directly. The Reporting Person is a member of the general partner and disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. |